Wallonia, the place to be for life sciences
Did you know …
That the density of Life Sciences activities per capita is three times higher in Belgium than it is in Germany ?

Wallonia, the southern region of Belgium, has naturally many things to offer when it comes to biotechnologies.
With its 5 universities,6 private research centers and 11,000 researcherspacked in a territory smaller than Saxony, the Walloon Life Sciences ecosystem is the best ecosystem to invest in !
There are many reasons to set up your German biotech company in Wallonia.
Here are some of them:
- Wallonia is first in the EU for pharma R&D investment per capita (Belgium)
- Belgium is second worldwide for clinical trials applications
- It is second worldwide in Biopharma Talent Development
- A vibrant ecosystem: more than 250 innovative SMEs are in Wallonia
Why should you choose Wallonia ?
- A high number of R&D incentives help companies in Belgium to reinforce their potential
- Wallonia is the biggest exporter of biopharmaceuticals
- Global biopharma and Life Sciences leaders like GSK and UCB are on Walloon ground
Meet us at BIO-Europe !
Get in touch and let´s arrange an online meeting or real one at BIO-Europe in November !
Want to know more about Wallonia ?
The Wallonia Export & Investment Agency can assist you. Get in touch and let's arrange an online meeting or let's meet in person at BIO-Europe in november !
Ludovic WAHA
Project Manager - Italy - Switzerland - Luxembourg
T +32 (0)81 33 29 02
They chose Wallonia to invest in Life Sciences.
Why not do it too ?
Investment of €300 million by the Japanese TAKEDA group in Lessines
with a view to establishing a new production line for plasma-based therapies.
[ Read more ]

UCB announces a one billion euro investment in its Braine-l'Alleud campus
UCB, a major player in the biopharmaceutical sector, has announced a major investment programme in Wallonia.
[ Read more ]

GSK is investing €330 million in a freeze-drying unit for vaccines in Wavre
GlaxoSmithKline is continuing to develop its pharmaceutical activities in Wallonia at its site in Wavre.
[ Read more ]
